This publication is an update of the 2005 guidelines for measuring national HIV prevalence in populationbased surveys of the UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. These guidelines are written for public health surveillance and programme officers responsible for monitoring the HIV epidemic ...

In Asia and the Pacific, an estimated 4.9 million people were living with HIV in 2012.  Although the rate of new HIV infections has decreased over the last decade, there are still an estimated 353 000 new infections each year in the region. HIV treatment ...

Health systems and services depend critically on the size, skills and commitment of the health workforce. It is now evident that in many low- and middle-income countries, meeting key Millennium Development Goal targets, specifically those relating to health, requires a significant increase in the numbers ...

The Guide to Monitoring and Evaluation of Advocacy, Communication, and Social Mobilization to Support Tuberculosis Prevention and Care was developed in response to this increased demand for broad-scope M&E of ACSM activities. While rigorous evaluation provides the best evidence to support scale-up of specific ACSM ...

First generation surveillance relied solely on data on AIDS cases and some sentinel studies on HIV prevalence. In 2000, a new strategy named second generation surveillance (SGS) was promoted to tailor surveillance systems to the epidemic state of a country (1). More specifically, the strategy ...

People living with the human immunodeficiency virus (HIV) are 29 times (26-31) more likely to develop tuberculosis (TB) disease as people without HIV and living in the same country. TB is a leading cause of death among people living with HIV, accounting for one in ...

Early initiation of ART in patients with CD4+ T-cell counts of less than 50 per cubic millimeter increased AIDS-free survival. Deferral of the initiation of ART to the first 4 weeks of the continuation phase of tuberculosis therapy in those with higher CD4+ T-cell counts ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

HIV testing is the gateway to HIV prevention, treatment, care and other support services. The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organisation (WHO) have endorsed global goals to achieve “zero new HIV infections, zero discrimination and zero AIDS-related deaths” by ...

Forging a Path to 90-90-90: Launch of WHO Guidelines on HIV Testing Services and UNAIDS/WHO Guidelines on Conducting National Population-based HIV Surveys

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

People reach HIV treatment, care, and the full range of prevention options through the gateway of HIV testing and counselling (HTC). Currently, most people with HIV do not know that they are infected; those who do know often test late; and poor linkages from HTC ...

Recommendations for the selection and use of HIV antibody tests were first issued by WHO in 1992.1 Since then the range of HIV antibody tests available has expanded. New types of assays have been developed and the overall quality has improved. HIV tests for other ...

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national HIV testing strategies or programmes in the countries of the European Union (EU) and the European Economic Area (EEA). It is intended to complement the following existing guidance: Scaling up HIV testing ...

These guidelines aim to: provide comprehensive evidence-based recommendations for HTS; support testing by trained lay providers to increase access to HTS through communitybased approaches; offer guidance to countries to deliver a mix of HTS approaches appropriate to their epidemic context, focusing on HTS for groups ...

National HIV testing guidelines are critical to the success and expansion of HIV testing services. This report sought to analyse national HIV testing policies in WHO focal countries. The focus of this review was two-fold: 1) To determine whether national HIV testing policies permit lay providers and ...

This document summarises the main outcomes of the Guidelines Development Group (GDG) meeting held in Geneva, Switzerland, from 9 to 11 November 2015 to advise the World Health Organization Global TB Programme (WHO/GTB) on the revision of the policies on drug-resistant tuberculosis treatment. This 2016 ...

The Tenth Meeting of the European Technical Advisory Group on Tuberculosis Control was held in Copenhagen on 9–10 November 2015. The objectives of the meeting were to: (i) review the epidemiology of TB and drug-resistant TB in the WHO European Region, including the burdens and trends; (ii) ...